Nidan Laboratories and Healthcare Ltd
NIDANNidan Laboratories and Healthcare Ltd
NIDAN
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 0.61 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.49 | 6.67 | 0.52% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Nidan Laboratories & Healthcare Ltd is a diagnostic imaging center operator.
Peers
Compare with peersMax Healthcare Institute Ltd
Apollo Hospitals Enterprise Ltd
Fortis Healthcare Ltd
Global Health Ltd
Narayana Hrudayalaya Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 20.98 | 22.19 | 21.44 | 30.06 | 27.60 | 26.93 | — | |||||||
Raw Materials | 1.72 | 2.56 | 2.23 | 3.20 | 1.24 | 0.95 | — | |||||||
| Power & Fuel Cost | 0.93 | 1.63 | 0.99 | 1.57 | 1.39 | 1.78 | ||||||||
| Employee Cost | 2.35 | 2.77 | 2.85 | 3.59 | 4.88 | 4.46 | ||||||||
| Selling & Administrative Expenses | 7.12 | 6.67 | 5.14 | 9.93 | 7.62 | 8.70 | ||||||||
| Operating & Other expenses | 0.64 | 0.92 | 0.28 | 1.96 | 2.33 | 8.35 | ||||||||
EBITDA | 8.22 | 7.64 | 9.95 | 9.81 | 10.14 | 2.69 | — | |||||||
| Depreciation/Amortization | 3.24 | 3.19 | 3.18 | 2.63 | 3.10 | 2.87 | — | |||||||
| PBIT | 4.98 | 4.45 | 6.77 | 7.18 | 7.04 | -0.18 | — | |||||||
| Interest & Other Items | 4.75 | 3.74 | 3.46 | 2.66 | 2.22 | 2.18 | — | |||||||
| PBT | 0.23 | 0.71 | 3.31 | 4.52 | 4.82 | -2.36 | — | |||||||
| Taxes & Other Items | 0.00 | 0.00 | 1.00 | 1.86 | 1.27 | 0.86 | — | |||||||
| Net Income | 0.23 | 0.71 | 2.31 | 2.66 | 3.55 | -3.22 | — | |||||||
| EPS | 0.23 | 0.72 | 2.33 | 2.24 | 2.55 | -2.32 | — | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Nidan Laboratories and Healthcare Ltd | -12.48 | 0.61 | — |
| Max Healthcare Institute Ltd | 106.23 | 13.36 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 116.19 | 14.26 | 0.22% |
| Fortis Healthcare Ltd | 84.74 | 5.93 | 0.15% |
Price Comparison
Compare NIDAN with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Mar 2023
Sep 2023
Mar 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
NIDAN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNidan Laboratories & Healthcare will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Nidan Laboratories & Healthcare announced that the 24th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 5.12%, vs industry avg of 10.02%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.06% to 0.04%